Table 4.
Detection rates of total antibodies (IgM/IgG) with Sienna® and Wondfo® in the two groups of patients among the three different stages
| Healthcare workers | Patients admitted to the Emergency Department | |||
|---|---|---|---|---|
| Sienna® (n = 93) | Wondfo® (n = 93) | Sienna® (n = 49) | Wondfo® (n = 21) | |
| IgM/IgG | IgM/IgG | IgM/IgG | IgM/IgG | |
| Early stage | 14/61 (22.9%) | 8/61 (13.1%) | 5/6 (83.3%) | 2/2 (100%) |
| Intermediate stage | 10/18 (55.5%) | 10/18 (55.5%) | 33/39 (84.6%) | 15/18 (83.3%) |
| Late stage | 8/14 (57.1%) | 5/14 (35.7%) | 4/4 (100%) | 1/1 (100%) |
| Total | 32/93 (34.4%) | 23/93 (24.7%) | 42/49 (85.7%) | 18/21 (85.7%) |